kabutan

EnBio Holdings, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 57%

Fri Feb 13, 2026 4:00 pm JST Earnings

6092 EnBio Holdings,Inc 【J-GAAP】

Earnings Report

EnBio Holdings,Inc <6092> [TSE Std] announced its financial results after the market closed on February 13th (16:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) increased 25.8% from the same period last year, reaching 1.09 billion yen.

In addition, the full-year forecast for consolidated ordinary profit has been revised upward 56.5%, from the previous forecast of 0.84 billion yen to 1.32 billion yen (compared to 0.70 billion yen in the previous period), increasing the growth rate from 20.2% to 88.2%. However, the full-year forecast for consolidated net income has decreased 85.9%, from the previous forecast of 0.71 billion yen to 0.10 billion yen (compared to 0.45 billion yen in the previous period). This changes the outlook from an anticipated profit increase to a projection of a 77.9% decrease in profit.

Based on the full-year plan announced by the company after the upward revision, our estimate of the consolidated ordinary profit for the October to March period (second half) is expected to increase 2.9 times, from the previous forecast of 0.24 billion yen to 0.72 billion yen (compared to 0.06 billion yen in the same period of the previous year), increasing the growth rate from 3.9 times to 11 times.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit surged 2.2 times that of the same period last year, reaching 0.49 billion yen. The operating profit margin drastically improved from 2.8% in the same period last year to 13.3%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 6,986 467 546 345 43.6 51.2 Feb 14, 2024 J-GAAP
Apr - Dec, 2024 8,191 835 869 565 69.8 123.8 Feb 14, 2025 J-GAAP
Apr - Dec, 2025 9,102 1,111 1,093 -65 -8.1 82.7 Feb 13, 2026 J-GAAP
YoY +11.1% +33.1% +25.8% － －

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2025 Prev 6,044 297 246 168 20.7 9 Nov 14, 2025 J-GAAP
Oct - Mar, 2025 New 7,115 773 723 -443 -54.6 9 Feb 13, 2026 J-GAAP
Revision Rate +17.7% +160.3% +193.9% － －

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 11,727 953 844 711 87.6 9 Aug 14, 2025 J-GAAP
Mar, 2026 New 12,798 1,429 1,321 100 12.3 9 Feb 13, 2026 J-GAAP
Revision Rate +9.1% +49.9% +56.5% -85.9% -85.9%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 4,709 67 63 37 4.6 9 May 15, 2025 J-GAAP
Oct - Mar, 2025 Guidance 7,115 773 723 -443 -54.6 9 Feb 13, 2026 J-GAAP
YoY +51.1% +1,053.7% +1,047.6% － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 9,575 815 1,067 708 88.9 8 May 15, 2024 J-GAAP
Mar, 2025 10,668 839 702 452 55.9 9 May 15, 2025 J-GAAP
Mar, 2026 Guidance 12,798 1,429 1,321 100 12.3 9 Feb 13, 2026 J-GAAP
YoY +20.0% +70.3% +88.2% -77.9% -78.0%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 2,232 63 230 150 18.5 2.8 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 2,477 4 -167 -113 -14.0 0.2 May 15, 2025 J-GAAP
Apr - Jun, 2025 2,438 117 31 9 1.1 4.8 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 3,245 539 567 534 66.0 16.6 Nov 14, 2025 J-GAAP
Oct - Dec, 2025 3,419 455 495 -608 -75.8 13.3 Feb 13, 2026 J-GAAP
YoY +53.2% +622.2% +115.2% － －

Related Articles